News
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing market. With dual compatibility across standard biopsy methods, BE-Smart is ...
Hoag has become the first hospital in the United States to offer a comprehensive, on-site program for a revolutionary, ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...
The company is positioning BE-Smart for near-term commercialization, targeting the $10 billion esophageal disease testing ...
A new study has found a striking increase in appendix cancer in Americans born after 1945, with older millennials ...
Alcohol associated cancer deaths have doubled in the U.S. over the past three decades, disproportionately impacting men and people 55 and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results